Literature DB >> 12144543

Severe cardiac toxicity after monoclonal antibody therapy.

G Damaj, M T Rubio, V Audard, O Hermine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12144543     DOI： 10.1034/j.1600-0609.2002.00712.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  3 in total

Review 1.  Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.

Authors:  Peter J Bugelski; Pauline L Martin
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Alemtuzumab induced ST-segment elevation and acute myocardial dysfunction.

Authors:  Shirin Attarian; Cindy Y Wang; Jorge Romero; Stefan K Barta; Santiago Aparo; Mark A Menegus
Journal:  J Cardiol Cases       Date:  2014-07-28

3.  Adverse cardiac events to monoclonal antibodies used for cancer therapy: The risk of Kounis syndrome.

Authors:  Nicholas G Kounis; George D Soufras; Grigorios Tsigkas; George Hahalis
Journal:  Oncoimmunology       Date:  2014-02-14       Impact factor: 8.110
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.